I  BioEnterprise


     Office Locations:

11000 Cedar Avenue
Cleveland, OH 44106
Phone: 216-658-3999
Fax: 216-658-3998



  • Seed



  • Life Sciences & Healthcare



    BioEnterprise is a business formation, recruitment, and acceleration initiative designed to grow health care companies and commercialize bioscience technologies. Based in Cleveland, BioEnterprise's founders and partners are Cleveland Clinic, University Hospitals, Case Western Reserve University, Summa Health System and BioInnovation Institute in Akron. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio. The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices: the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group. Companies include emerging medical device, biotechnology, and health care services firms. Each year, the BioEnterprise groups choose a select number of companies on which to focus. The resources and networks of the BioEnterprise partners are directed to help those companies achieve greater levels of business success. Since July 2002, the BioEnterprise Initiative has achieved: more than 350 companies created, recruited, and acclerated; more than $2 billion in new funding attracted by these companies; over $210 million in revenues collected by technology offices; and over 1,900 company opportunities and 3,400 invention disclosures.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Annette Ballou Vice President, Strategic Marketing & Communications
    Aram Nerpouni President and CEO
    Deirdre Gannon Vice President, Strategic Development
    Jim Weisman CEO-in-Residence
    Karen Spilizewski Vice President


    Portfolio companies include:

      Accord Biosciences
        web link

        web link

        web link

      Alltech Medical Systems
        web link

      American Safety & Health Institute
        web link

        web link

      Aris Teleradiology
        web link

        web link

        web link

        web link

        web link

        web link

        web link

      Cell Targeting
        web link

        web link


        web link

      Checkpoint Surgical
        web link

      Cleveland Heart
        web link

      Cleveland HeartLab
        web link

      COMS Interactive
        web link

      Copernicus Therapeutics
        web link

      CornerStone Medical Services
        web link

        web link

      Cryothermic Systems
        web link

        web link

      ERIS Medical Technologies
        web link

      FMI ScintiScan
        web link

      ForTec Companies
        web link

      Freedom Meditech
        web link

      Future Path Medical
        web link

        web link

      Tolera Therapeutics
        web link

        web link


    Recent News: